Cargando…

Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients

This study was performed to demonstrate urinary angiotensinogen as a potential prognostic marker of the albuminuria reduction effects of olmesartan in patients with metabolic syndrome. In 24 patients (eight women, 57.88 ± 2.00 years), 5–40 mg/day of olmesartan were given. Urinary concentrations of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizushige, Tomoko, Kobori, Hiroyuki, Hitomi, Hirofumi, Nishijima, Yoko, Tomoda, Fumihiro, Morimoto, Satoshi, Kohno, Masakazu, Nishiyama, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133801/ https://www.ncbi.nlm.nih.gov/pubmed/27801805 http://dx.doi.org/10.3390/ijms17111800

Ejemplares similares

Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes
por: Mizushige, Tomoko, et al.
Publicado: (2015)

Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease
por: Nishijima, Yoko, et al.
Publicado: (2014)

Early Treatment With Olmesartan Prevents Juxtamedullary Glomerular Podocyte Injury and the Onset of Microalbuminuria in Type 2 Diabetic Rats
por: Sofue, Tadashi, et al.
Publicado: (2012)

Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes
por: Yoshimoto, Takuo, et al.
Publicado: (2017)

Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy
por: Kamiyama, Masumi, et al.
Publicado: (2013)

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy
por: Ogawa, Susumu, et al.
Publicado: (2009)

Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus
por: Sawaguchi, Makoto, et al.
Publicado: (2012)

High glucose augments angiotensinogen in human renal proximal tubular cells through hepatocyte nuclear factor-5
por: Wang, Juan, et al.
Publicado: (2017)

Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes
por: Cruz‐López, Edwyn O., et al.
Publicado: (2022)

Detailed Localization of Augmented Angiotensinogen mRNA and Protein in Proximal Tubule Segments of Diabetic Kidneys in Rats and Humans
por: Kamiyama, Masumi, et al.
Publicado: (2014)

Urinary Angiotensinogen Is Elevated in Patients with Nephrolithiasis
por: Sun, Wei, et al.
Publicado: (2014)

Intrarenal Oxidative Stress and Augmented Angiotensinogen are Precedent to Renal Injury in Zucker Diabetic Fatty Rats
por: Suzaki, Yuki, et al.
Publicado: (2006)

Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT(1) Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice
por: Rafiq, Kazi, et al.
Publicado: (2013)

Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy
por: Takamatsu, Masanori, et al.
Publicado: (2008)

Possible renoprotective mechanisms of SGLT2 inhibitors
por: Nishiyama, Akira, et al.
Publicado: (2023)

Urinary Angiotensinogen as a Biomarker of Nephropathy in Childhood
por: Urushihara, Maki, et al.
Publicado: (2011)

The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules
por: Ohashi, Naro, et al.
Publicado: (2019)

Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes
por: Terami, Takahiro, et al.
Publicado: (2013)

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014)

Urinary excretion of renin and angiotensinogen in hypertensive children and adolescents
por: Zając, Magdalena, et al.
Publicado: (2019)

Urinary Angiotensinogen-Melatonin Ratio in Gestational Diabetes and Preeclampsia
por: Valias, Gabriela Ribeiro, et al.
Publicado: (2022)

Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes
por: Soltysiak, Jolanta, et al.
Publicado: (2014)

The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2018)

Effect of Vitamin D on Urinary Angiotensinogen Level in Early Diabetic Nephropathy
por: Mahapatra, Himansu Sekhar, et al.
Publicado: (2021)

Elevated urinary angiotensinogen excretion links central and renal hemodynamic alterations
por: Kosaki, Keisei, et al.
Publicado: (2023)

Short-Term Calorie Restriction in Early Life Attenuates the Development of Proteinuria but Not Glucose Intolerance in Type 2 Diabetic OLETF Rats
por: Nakano, Daisuke, et al.
Publicado: (2011)

Structure and functions of angiotensinogen
por: Lu, Hong, et al.
Publicado: (2016)

Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion
por: Mansuri, Asifhusen, et al.
Publicado: (2015)

Correction to: The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2019)

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
por: Daikuhara, Hiroyuki, et al.
Publicado: (2014)

Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients
por: Sofue, Tadashi, et al.
Publicado: (2014)

Regression of Glomerular and Tubulointerstitial Injuries by Dietary Salt Reduction with Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker in Dahl Salt-Sensitive Rats
por: Rafiq, Kazi, et al.
Publicado: (2014)

Prednisolone Co-Administered with Losartan Confers Renoprotection in Patients with IgA Nephropathy
por: Horita, Yoshio, et al.
Publicado: (2007)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015)

Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension
por: Kuroczycka-Saniutycz, Elżbieta, et al.
Publicado: (2013)

Urinary angiotensinogen as a marker of elevated blood pressure in patients with chronic kidney disease
por: Jung, Chan-Young, et al.
Publicado: (2021)

Urinary Angiotensinogen and Progression of Chronic Kidney Disease: Results from KNOW-CKD Study
por: Suh, Sang Heon, et al.
Publicado: (2022)

Relationship Between Urinary Angiotensinogen and Mortality in Patients with Heart Failure with Reduced Ejection Fraction
por: Örsçelik, Özcan, et al.
Publicado: (2023)

Angiotensinogen and the Modulation of Blood Pressure
por: Shu, Zimei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s7rjnidtlaf5o5hmgjrp4li8ui